Live Breaking News & Updates on Alim

Stay informed with the latest breaking news from Alim on our comprehensive webpage. Get up-to-the-minute updates on local events, politics, business, entertainment, and more. Our dedicated team of journalists delivers timely and reliable news, ensuring you're always in the know. Discover firsthand accounts, expert analysis, and exclusive interviews, all in one convenient destination. Don't miss a beat — visit our webpage for real-time breaking news in Alim and stay connected to the pulse of your community

StockNews.com Lowers Alimera Sciences (NASDAQ:ALIM) to Hold

Alimera Sciences (NASDAQ:ALIM – Get Free Report) was downgraded by analysts at StockNews.com from a “buy” rating to a “hold” rating in a report released on Friday. Separately, Maxim Group initiated coverage on Alimera Sciences in a research note on Monday, March 25th. They set a “buy” rating and a $10.00 price objective on the […]

United-states , Citadel-advisors , Northern-trust-corp , Alimera-sciences , Osaic-holdings-inc , Alimera-sciences-inc , Alimera-sciences-company-profile , Maxim-group , Tower-research-capital , Hedge-funds-weigh-in-on-alimera-sciences , Alimera-sciences-trading-down

Usual suspects and the debatable: What are your favourite iftar items?

The dining table during iftar is often crowded with delicacies of all sorts. The assortment includes traditional iftar items and not-so-traditional items which may even border on eccentricity that leaves others questioning about your taste (and sanity). Call it "iftar cuisine" if you like, as an iftar spread is a whole different genre of food altogether! So, we asked around

Bangladesh , Turkey , Bombay , Maharashtra , India , Mirpur , Bangladesh-general- , Turkish , Bangladeshi , Riazul-islam , Tamim-faroque , Rooh-afza

Alimera Sciences (NASDAQ:ALIM) Coverage Initiated by Analysts at StockNews.com

StockNews.com assumed coverage on shares of Alimera Sciences (NASDAQ:ALIM – Free Report) in a research note released on Sunday. The firm issued a hold rating on the biopharmaceutical company’s stock. Alimera Sciences Price Performance Shares of NASDAQ ALIM opened at $3.90 on Friday. The business has a fifty day moving average price of $3.56 and […]

United-states , Alimera-sciences-inc , Alimera-sciences-price-performance , Institutional-investors-weigh-in-on-alimera-sciences , Susquehanna-international-group , News-ratings-for-alimera-sciences-daily , Alimera-sciences , Capital-management , Worth-venture-partners , Stonepine-capital-management , Free-report

Alimera Sciences (NASDAQ:ALIM) Earns Hold Rating from Analysts at StockNews.com

StockNews.com started coverage on shares of Alimera Sciences (NASDAQ:ALIM – Free Report) in a report published on Sunday morning. The brokerage issued a hold rating on the biopharmaceutical company’s stock. Alimera Sciences Price Performance Shares of NASDAQ:ALIM opened at $4.08 on Friday. Alimera Sciences has a 52 week low of $1.30 and a 52 week […]

United-states , Capital-management , Vanguard-group-inc , Nasdaq , Tower-research-capital , Alimera-sciences-inc , News-ratings-for-alimera-sciences-daily , Alimera-sciences-price-performance , Stonepine-capital-management , Alimera-sciences , Worth-venture-partners

StockNews.com Initiates Coverage on Alimera Sciences (NASDAQ:ALIM)

StockNews.com started coverage on shares of Alimera Sciences (NASDAQ:ALIM – Free Report) in a report published on Saturday. The firm issued a hold rating on the biopharmaceutical company’s stock. Alimera Sciences Price Performance Shares of NASDAQ:ALIM opened at $3.81 on Friday. The company’s fifty day moving average price is $3.44 and its 200 day moving […]

United-states , Tower-research-capital , Vanguard-group-inc , News-ratings-for-alimera-sciences-daily , Alimera-sciences-price-performance , Stonepine-capital-management , Nasdaq , Alimera-sciences-inc , Capital-management , Alimera-sciences , Worth-venture-partners

Alimera Sciences (NASDAQ:ALIM) Earns Hold Rating from Analysts at StockNews.com

StockNews.com started coverage on shares of Alimera Sciences (NASDAQ:ALIM – Free Report) in a research report report published on Thursday morning. The firm issued a hold rating on the biopharmaceutical company’s stock. Separately, HC Wainwright reissued a buy rating and set a $5.00 price objective on shares of Alimera Sciences in a report on Monday, […]

United-states , Alimera-sciences-trading , Alimera-sciences , Capital-management , Alimera-sciences-company-profile , Stonepine-capital-management , Institutional-trading-of-alimera-sciences , News-ratings-for-alimera-sciences-daily , Susquehanna-international-group , Alimera-sciences-inc , Worth-venture-partners

Alimera Sciences (NASDAQ:ALIM) Research Coverage Started at StockNews.com

StockNews.com started coverage on shares of Alimera Sciences (NASDAQ:ALIM – Free Report) in a research report released on Wednesday. The firm issued a hold rating on the biopharmaceutical company’s stock. Separately, HC Wainwright reiterated a buy rating and issued a $5.00 target price on shares of Alimera Sciences in a report on Monday, August 14th. […]

United-states , Tower-research-capital , Renaissance-technologies , Nasdaq , Geode-capital-management , Osaic-holdings-inc , Millennium-management , Alimera-sciences-trading , News-ratings-for-alimera-sciences-daily , Alimera-sciences , Alimera-sciences-company-profile

StockNews.com Begins Coverage on Alimera Sciences (NASDAQ:ALIM)

StockNews.com started coverage on shares of Alimera Sciences (NASDAQ:ALIM – Free Report) in a research note issued to investors on Wednesday morning. The brokerage issued a hold rating on the biopharmaceutical company’s stock. Separately, HC Wainwright reissued a buy rating and set a $5.00 price objective on shares of Alimera Sciences in a research report […]

United-states , Osaic-holdings-inc , Millennium-management , Alimera-sciences-inc , Securities-exchange-commission , Renaissance-technologies , News-ratings-for-alimera-sciences-daily , Alimera-sciences-company-profile , Geode-capital-management , Susquehanna-international-group , Alimera-sciences-price-performance

Alimera Sciences (NASDAQ:ALIM) Research Coverage Started at StockNews.com

StockNews.com began coverage on shares of Alimera Sciences (NASDAQ:ALIM – Free Report) in a research report report published on Saturday morning. The brokerage issued a hold rating on the biopharmaceutical company’s stock. Separately, HC Wainwright reissued a buy rating and issued a $5.00 price objective on shares of Alimera Sciences in a research note on […]

United-states , Millennium-management , Geode-capital-management , Securities-exchange-commission , Osaic-holdings-inc , Alimera-sciences-inc , News-ratings-for-alimera-sciences-daily , Renaissance-technologies , Alimera-sciences , Insider-activity-at-alimera-sciences , Institutional-investors-weigh-in-on-alimera-sciences

Alimera Sciences (NASDAQ:ALIM) Coverage Initiated by Analysts at StockNews.com

StockNews.com assumed coverage on shares of Alimera Sciences (NASDAQ:ALIM – Free Report) in a research report released on Saturday. The brokerage issued a hold rating on the biopharmaceutical company’s stock. Separately, HC Wainwright restated a buy rating and set a $5.00 price objective on shares of Alimera Sciences in a research report on Monday, August […]

United-states , Alimera-sciences-inc , Alimera-sciences , Securities-exchange-commission , Osaic-holdings-inc , News-ratings-for-alimera-sciences-daily , Hedge-funds-weigh-in-on-alimera-sciences , Geode-capital-management , Susquehanna-international-group , Millennium-management , Alimera-sciences-company-profile